Search research articles
Contact Us
Filters
Showing results (101-110 of 218) with videos related to
Page
of 22
Sort By:
Blood Cancer Journal
|
May 23, 2019
ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial
Roya Rafiee, Lata Chauhan, Todd A Alonzo, et al.
Haematologica
|
February 8, 2020
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group
Richard Aplenc, Soheil Meshinchi, Lillian Sung, et al.
BMC Bioinformatics
|
June 28, 2023
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Alyssa N Obermayer, Darwin Chang, Gabrielle Nobles, et al.
Blood
|
August 23, 2014
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report
Fabiana Ostronoff, Megan Othus, Robert B Gerbing, et al.
Pediatric Blood & Cancer
|
August 12, 2016
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group
Ranjani Ramamurthy, Maya Hughes, Valerie Morris, et al.
Cancers
|
December 10, 2021
Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies
Anilkumar Gopalakrishnapillai, Colin E Correnti, Kristina Pilat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2010
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group
Roland B Walter, Todd A Alonzo, Robert B Gerbing, et al.
Blood
|
April 24, 2010
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
Phoenix A Ho, Rong Zeng, Todd A Alonzo, et al.
Genes, Chromosomes & Cancer
|
October 3, 2007
Identification of genes with abnormal expression changes in acute myeloid leukemia
Derek L Stirewalt, Soheil Meshinchi, Kenneth J Kopecky, et al.
JCO Precision Oncology
|
September 11, 2020
CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Lata Chauhan, Miyoung Shin, Yi-Cheng Wang, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 218) with videos related to
Sort By:
Page
of 22
Blood Cancer Journal
|
May 23, 2019
ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial
Roya Rafiee, Lata Chauhan, Todd A Alonzo, et al.
Haematologica
|
February 8, 2020
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group
Richard Aplenc, Soheil Meshinchi, Lillian Sung, et al.
BMC Bioinformatics
|
June 28, 2023
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Alyssa N Obermayer, Darwin Chang, Gabrielle Nobles, et al.
Blood
|
August 23, 2014
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report
Fabiana Ostronoff, Megan Othus, Robert B Gerbing, et al.
Pediatric Blood & Cancer
|
August 12, 2016
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group
Ranjani Ramamurthy, Maya Hughes, Valerie Morris, et al.
Cancers
|
December 10, 2021
Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies
Anilkumar Gopalakrishnapillai, Colin E Correnti, Kristina Pilat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2010
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group
Roland B Walter, Todd A Alonzo, Robert B Gerbing, et al.
Blood
|
April 24, 2010
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
Phoenix A Ho, Rong Zeng, Todd A Alonzo, et al.
Genes, Chromosomes & Cancer
|
October 3, 2007
Identification of genes with abnormal expression changes in acute myeloid leukemia
Derek L Stirewalt, Soheil Meshinchi, Kenneth J Kopecky, et al.
JCO Precision Oncology
|
September 11, 2020
CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Lata Chauhan, Miyoung Shin, Yi-Cheng Wang, et al.
Page
of 22